Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.26.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities:    
Net loss $ (743) $ (8,059)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization 5,346 9,608
Amortization and write off of debt issuance costs 234 123
Amortization and write off of discount on long-term debt 2,421 5,995
Change in contingent consideration from acquisitions (5,591) (7,482)
Non-cash lease expense 2,846 3,173
Change in tax receivable agreement liability 0 1,331
Bad debt expense 988 2,786
Equity-based compensation 5,720 8,341
Non-cash interest (1,473) (1,552)
Gain on disposal of assets and lease terminations (718) (5,021)
Gain on divestitures 0 (4,866)
Change in contingent consideration receivable from Lindora 3,574 0
Impairment of goodwill and other noncurrent assets 0 32,411
Changes in assets and liabilities, net of effect of acquisition:    
Accounts receivable 3,147 4,517
Inventories (3,075) 4,355
Prepaid expenses and other current assets 4,155 (12,344)
Operating lease liabilities (2,958) (2,772)
Deferred costs 3,989 6,146
Notes receivable, net 4 3
Accounts payable (2,960) (11,390)
Accrued expenses (30,669) 1,994
Other current liabilities 266 (3,837)
Deferred revenue (7,536) (17,537)
Other assets 108 1,547
Other liabilities 1,824 10,170
Net cash provided by (used in) operating activities (21,101) 17,640
Cash flows from investing activities:    
Purchases of property and equipment (1,282) (3,070)
Purchase of intangible assets (1,097) (1,224)
Notes receivable issued 0 (173)
Notes receivable payments received 273 169
Proceeds from disposition of brands 0 2,000
Net cash used in investing activities (2,106) (2,298)
Cash flows from financing activities:    
Borrowings from long-term debt, net of original discount issue 0 10,000
Payments on long-term debt (3,938) (4,123)
Debt issuance costs 0 (90)
Payment of preferred stock dividend 0 (5,694)
Payment of promissory note liability 0 (3,392)
Borrowings from line of credit 10,000 0
Payments of contingent consideration 0 (500)
Payments for taxes related to net share settlement of restricted share units (1,285) (2,296)
Proceeds from issuance of common stock in connection with stock-based compensation plans 58 122
Payments for distributions to Pre-IPO LLC Members (169) (483)
Reimbursement from shareholder (Note 9) (139) (162)
Net cash provided by (used in) financing activities 4,527 (6,618)
Increase (decrease) in cash, cash equivalents and restricted cash (18,680) 8,724
Cash, cash equivalents and restricted cash, beginning of period 45,863 32,739
Cash, cash equivalents and restricted cash, end of period 27,183 41,463
Supplemental cash flow information:    
Interest paid 45,645 30,966
Income taxes paid, net 211 252
Non-cash investing and financing activities::    
Capital expenditures accrued at period end 488 767
Debt issuance costs paid-in-kind - long-term debt 0 10,872
Debt issuance costs exit fees - long-term debt 0 7,248
Notes receivable $ 0 $ 5,000